Cerveau Technologies

Provider of information and technology for researchers and clinicians in neurodegenerative disease research, enabling molecular imaging and biomarker access.

Provider of information and technology to researchers and clinicians intended to treat neurodegenerative diseases. The company offers broad access to biomarkers of neurological pathologies, essential enabling tools and information technology to revolutionize the use of molecular imaging, helping healthcare industries to accelerate the development and approval of effective therapies to treat Alzheimer's and other neurodegenerative diseases.

Knoxville, United StatesHealthcare

Visit Cerveau Technologies

Partnerships

Clients

Team

Tanya.laiken@cerveautechnologies.com

tanya.laiken@cerveautechnologies.com

Team member

Team

Founded

2016

Featured companies:

Similar to Cerveau Technologies

View all companies

European Paediatric Neurology Data (EPND)

Working together to accelerate biomarker discovery, development, and validation across Europe and the world.

Platform Provider

Barrow Neurological Institute - St. Joseph's

Minding What Matters Most

Phoenix, United States

Caraway Therapeutics

Developer of novel drug designed for doctors to treat neurodegenerative diseases. The company develops treatments that modulate mitophagy and autophagy by leveraging an understanding of critical neural pathways to discover and develop novel small molecules that will restore cellular balance and target lysosomes to modulate and restore their activity to prevent neurodegenerative diseases, enabling physicians to improve the lives of patients suffering from a range of neurodegenerative diseases and senescence.

Cambridge, United States